Target intelligence / Profile preview

Multiple viral and host proteins

Molecular classification
Other
01

Overview

"Multiple viral and host proteins" refers to the ensemble of proteins encoded by viruses and their corresponding interacting partners in the host organism's proteome. These interactions govern essential processes such as viral entry, replication, immune modulation, and pathogenesis. The term is not a canonical molecular target but rather comprises thousands of unique protein-protein interactions across diverse viral and host genomes. Therapeutically, targeting virus-host protein interactions (rather than viral proteins alone) is a strategy to combat infection, increase the genetic barrier to resistance, and potentially enable broad-spectrum antiviral development. However, such approaches must carefully balance antiviral efficacy with preservation of normal host cell biology due to possible off-target effects[1][5][7]. This entry is too broad and non-specific to be considered a valid individual drug target for most structured therapeutic databases. Instead, each involved virus or host protein (e.g., CCR5, ACE2) would constitute a separate, manageable entry[1][5][7].

Other names
Virus-host interaction proteinsViral-host protein-protein interactions (PPIs)Host dependency factors (when referring to host proteins essential for viral infection)
02

Mechanism of action

Inhibition of critical virus-host protein-protein interactions Modulation of host pathways essential for viral replication[1][5][7]

03

Biological functions

Viral entryViral replicationImmune response modulationSignal transduction (host-directed)Intracellular trafficking
04

Disease associations

InfectionOther (role would depend on the individual protein)
05

Safety considerations

Potential for significant off-target toxicity due to interference with essential host cell functions[1][5].Risk of deleterious effects on normal cellular processes.
06

Interacting drugs

No drugs interact universally with "multiple viral and host proteins". However, some drugs targeting host factors essential to multiple viruses have been investigated, e.g., broad-spectrum antivirals or repurposed drugs such as Maraviroc (targets CCR5, a host protein interacting with viral proteins)[1][7]. Specific drugs depend on the individual protein target in the virus-host interactome.
07

Biomarkers

No universal biomarkers; selection depends on the specific protein or pathway being targeted.

Beyond the preview

Go deeper on Multiple viral and host proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple viral and host proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call